Ultragenyx Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US90400D1081

SecurityRARE / Ultragenyx Pharmaceutical Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in RARE / Ultragenyx Pharmaceutical Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Ultragenyx Pharmaceutical Inc. (US:RARE) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 200,717 shares of Ultragenyx Pharmaceutical Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -100.00 0
2025-11-13 2025-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 200,717 -34,380 -14.62 6,038 -29.36 0.0070
2025-08-14 2025-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 235,097 -48,452 -17.09 8,548 -16.74 0.0105
2025-08-14 2025-03-31 13F/A-1 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 283,549 586 0.21 10,267 -13.75 0.0127
2025-05-15 2025-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 283,549 586 10,267 0.0084
2025-02-14 2024-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 282,963 7,036 2.55 11,904 -22.34 0.0144
2024-11-14 2024-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 275,927 46,445 20.24 15,328 62.51 0.0165
2024-08-09 2024-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 229,482 9,165 4.16 9,432 -8.31 0.0108
2024-05-14 2024-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 220,317 -3,919 -1.75 10,287 -4.07 0.0117
2024-02-14 2023-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 224,236 7,000 3.22 10,723 38.47 0.0124
2023-11-14 2023-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 217,236 1,568 0.73 7,744 -22.16 0.0097
2023-10-27 2023-06-30 13F/A-2 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 215,668 -735,522 -77.33 9,949 -73.92 0.0114
2023-10-12 2023-06-30 13F/A-1 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 215,668 -735,522 9,949 0.0100
2023-08-14 2023-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 215,668 -735,522 9,949 0.0101
2023-06-01 2023-03-31 13F/A-1 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 951,190 -182,222 -16.08 38,143 -27.36 0.0453
2023-05-15 2023-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 951,190 -182,222 38,143 0.0350
2023-02-21 2022-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,133,412 14,017 1.25 52,511 13.21 0.0620
2022-11-14 2022-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,119,395 8,834 0.80 46,384 -29.99 0.0569
2022-08-17 2022-06-30 13F/A-1 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,110,561 32,537 3.02 66,256 -15.37 0.0744
2022-08-15 2022-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,110,561 32,537 66,256 0.0237
2022-05-16 2022-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,078,024 153,852 16.65 78,287 0.74 0.0595
2022-02-11 2021-12-31 13F Ultragenyx Pharmaceutical COM 90400D108 924,172 -7,097 -0.76 77,714 -7.47 0.0648
2021-11-12 2021-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 931,269 -2,408 -0.26 83,991 -5.66 0.0716
2021-08-13 2021-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 933,677 -91,862 -8.96 89,026 -23.76 0.0731
2021-05-14 2021-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,025,539 -141,122 -12.10 116,768 -27.70 0.1651
2021-02-16 2020-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,166,661 -195,692 -14.36 161,501 44.23 0.2358
2020-11-13 2020-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,362,353 -164,662 -10.78 111,972 -6.25 0.1896
2020-08-11 2020-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,527,015 -95,487 -5.89 119,443 65.69 0.2057
2020-05-15 2020-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,622,502 208,293 14.73 72,087 19.35 0.1481
2020-03-18 2019-12-31 13F/A-2 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,414,209 178,196 14.42 60,401 14.23 0.0862
2020-02-28 2019-12-31 13F/A-1 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,414,209 0 60,401 0.0873
2020-02-14 2019-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,414,209 178,196 60,401 75,798.1361
2019-11-14 2019-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,236,013 438,720 55.03 52,877 4.44 0.0886
2019-11-06 2019-06-30 13F/A-2 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 797,293 130,561 19.58 50,628 9.48 0.0854
2019-09-24 2019-06-30 13F/A-1 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 797,293 0 50,628 0.0861
2019-08-14 2019-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 797,293 130,561 50,628
2019-05-15 2019-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 666,732 310,530 87.18 46,244 198.60 0.0789
2019-02-15 2018-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 356,202 93,625 35.66 15,487 -22.74 0.0299
2018-11-15 2018-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 262,577 262,577 20,045 0.0327
2017-05-15 2017-03-31 13F Ultragenyx Pharmaceutical COMMON 90400D108 0 -12,900 -100.00 0 -100.00
2017-03-30 2016-12-31 13F/A-1 Ultragenyx Pharmaceutical COMMON 90400D108 12,900 -1,800 -12.24 907 -13.04 0.0017
2017-02-15 2016-12-31 13F Ultragenyx Pharmaceutical COMMON 90400D108 12,900 907
2016-11-15 2016-09-30 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 14,700 3,000 25.64 1,043 82.34 0.0020
2016-09-14 2016-06-30 13F/A-1 ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 11,700 -34,933 -74.91 572 -80.62 0.0011
2016-08-15 2016-06-30 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 11,700 572
2016-05-16 2016-03-31 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 46,633 -9,809 -17.38 2,952 -53.38 0.0059
2016-02-16 2015-12-31 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 56,442 6,258 12.47 6,332 31.02 0.0130
2015-11-16 2015-09-30 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 50,184 -7,153 -12.48 4,833 -17.68 0.0104
2015-08-21 2015-06-30 13F/A-1 ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 57,337 28,337 97.71 5,871 225.99 0.0116
2015-08-14 2015-06-30 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 57,337 5,871
2015-05-18 2015-03-31 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 29,000 19,138 194.06 1,801 315.94 0.0035
2015-02-17 2014-12-31 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 9,862 0 0.00 433 -22.40 0.0009
2014-11-14 2014-09-30 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 9,862 0 0.00 558 25.96 0.0012
2014-08-14 2014-06-30 13F ULTRAGENYX PHARMACEUTICAL COMMON 90400D108 9,862 0 0.00 443 -8.09 0.0010
2014-05-15 2014-03-31 13F ULTRAGENYX PHARMACEUTICAL Common 90400D108 9,862 9,862 482 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.